ATE359088T1 - Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten - Google Patents
Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheitenInfo
- Publication number
- ATE359088T1 ATE359088T1 AT02029016T AT02029016T ATE359088T1 AT E359088 T1 ATE359088 T1 AT E359088T1 AT 02029016 T AT02029016 T AT 02029016T AT 02029016 T AT02029016 T AT 02029016T AT E359088 T1 ATE359088 T1 AT E359088T1
- Authority
- AT
- Austria
- Prior art keywords
- interleukin
- treat
- skin diseases
- associated skin
- diseases
- Prior art date
Links
- 102000003810 Interleukin-18 Human genes 0.000 title abstract 2
- 108090000171 Interleukin-18 Proteins 0.000 title abstract 2
- 208000017520 skin disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02029016A EP1433484B1 (de) | 2002-12-27 | 2002-12-27 | Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359088T1 true ATE359088T1 (de) | 2007-05-15 |
Family
ID=32405728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02029016T ATE359088T1 (de) | 2002-12-27 | 2002-12-27 | Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060115452A1 (de) |
| EP (1) | EP1433484B1 (de) |
| JP (1) | JP2006512383A (de) |
| AT (1) | ATE359088T1 (de) |
| AU (1) | AU2003298219B2 (de) |
| CA (1) | CA2511612A1 (de) |
| DE (1) | DE60219495T2 (de) |
| ES (1) | ES2284774T3 (de) |
| NZ (1) | NZ541184A (de) |
| WO (1) | WO2004058294A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
| CA2566877A1 (en) * | 2004-05-17 | 2005-11-24 | Keio University | Medicinal composition and therapeutic method |
| WO2006009114A1 (ja) * | 2004-07-16 | 2006-01-26 | Atsuo Sekiyama | Ｉｌ－１８レセプターアンタゴニスト、および当該アンタゴニストを含む薬学的組成物 |
| US20100061958A1 (en) | 2006-09-14 | 2010-03-11 | The Trustees Of The University Of Pennsylvania | Modulation of Regulatory T Cells by Human IL-18 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3955352B2 (ja) * | 1997-02-25 | 2007-08-08 | 株式会社林原生物化学研究所 | 破骨細胞形成阻害剤 |
-
2002
- 2002-12-27 DE DE60219495T patent/DE60219495T2/de not_active Expired - Fee Related
- 2002-12-27 ES ES02029016T patent/ES2284774T3/es not_active Expired - Lifetime
- 2002-12-27 AT AT02029016T patent/ATE359088T1/de not_active IP Right Cessation
- 2002-12-27 EP EP02029016A patent/EP1433484B1/de not_active Expired - Lifetime
-
2003
- 2003-12-19 NZ NZ541184A patent/NZ541184A/en unknown
- 2003-12-19 JP JP2004562807A patent/JP2006512383A/ja active Pending
- 2003-12-19 US US10/539,827 patent/US20060115452A1/en not_active Abandoned
- 2003-12-19 CA CA002511612A patent/CA2511612A1/en not_active Abandoned
- 2003-12-19 AU AU2003298219A patent/AU2003298219B2/en not_active Ceased
- 2003-12-19 WO PCT/EP2003/014633 patent/WO2004058294A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1433484B1 (de) | 2007-04-11 |
| AU2003298219A1 (en) | 2004-07-22 |
| CA2511612A1 (en) | 2004-07-15 |
| NZ541184A (en) | 2008-04-30 |
| JP2006512383A (ja) | 2006-04-13 |
| AU2003298219B2 (en) | 2007-11-29 |
| AU2003298219B8 (en) | 2004-07-22 |
| ES2284774T3 (es) | 2007-11-16 |
| DE60219495D1 (de) | 2007-05-24 |
| WO2004058294A1 (en) | 2004-07-15 |
| EP1433484A1 (de) | 2004-06-30 |
| US20060115452A1 (en) | 2006-06-01 |
| DE60219495T2 (de) | 2007-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE60325209D1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
| DE60328517D1 (de) | Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| ATE428413T1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| ATE525480T1 (de) | Verwendung von a33-antigenen und jam-it | |
| DE60314730D1 (de) | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
| ATE416756T1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| DE60323533D1 (de) | Methode zur stimulierung von haarwuchs auf der basis von benzopyranen | |
| ATE361755T1 (de) | Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen | |
| ATE549026T1 (de) | Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren | |
| ATE359088T1 (de) | Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten | |
| ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE50212649D1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| DE602004024871D1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
| ATE300944T1 (de) | Verwendung von substituierten distamycin- acryloylderivaten zur behandlung von tumoren die mit erhöhten glutathion-spiegeln zusammenhängen | |
| DE50308460D1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen | |
| DE602004011486D1 (de) | Kombinierte verwendung von einem fibrat und von orlistat zur behandlung von obesitas | |
| DE502004012196D1 (de) | Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1433484 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |